(Q83772197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

A Dominietto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

E Tedone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Soracco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

B Bruno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A M Raiola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M T Van Lint

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

S Geroldi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

T Lamparelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

B Galano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

F Gualandi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Bacigalupo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

4 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

101-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21460867%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2011.28

27 January 2020

exact match

0 references

cites work

Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

The role of B cells in the pathogenesis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021

Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.28

7 January 2021